Candel Therapeutics Inc
candeltx.comWhat Do They Do?
Develops off-the-shelf virus-based cancer treatment candidates designed to trigger immune responses against tumors in patients with cancer.
10-K for FY2025, filed Mar 12, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 13, 2026
−$38.9MView ↗
- ▲ +711% (Loss)
- vs −$4.8M in Q2 FY2025
Who Do They Compete With?
Competes with Replimune Group, Amgen, Astellas Pharma, Istari Oncology, Orca Therapeutics, CG Oncology, ImmVira, IconOVir Bio, and FerGene
10-K for FY2025, filed Mar 12, 2026Some of the products and therapies developed by our competitors are based on scientific approaches that are the same as or similar to our…View ↗
Loading...
